NCT04318665View on ClinicalTrials.gov

Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

August 2, 2023

Study Completion Date

August 2, 2023

Conditions

Traumatic Brain Injury

Interventions

DIAGNOSTIC_TEST

CT Perfusion

Severe Traumatic Brain Injury patients will be undergoing CT perfusion test

Trial Locations (4)

R3A 1R9

Health Sciences Centre, Winnipeg

B3K 4N1

QEII Health Scienecs Centre, Halifax

K1Y 4E9

The Ottawa Hospital, Ottawa

H2X 0C1

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Manitoba

OTHER

NCT04318665 - Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study) | Biotech Hunter | Biotech Hunter